focus -WSS

focus

author：comprehensive 2025-08-11 16:24:17 - browse：65538

-- health policy coverage from STAT — Protestors outside America's Health Insurance Plans headquarters. Courtesy People's Action

WASHINGTON — Hundreds of activists rallied today outside of the headquarters of the country’s largest health insurance lobbying group to protest against restrictions to coverage in private Medicare plans.

The protesters were crammed into an already busy part of the city. A 10-minute walk from the Capitol building and a block off the National Mall, the headquarters for America’s Health Insurance Plans is located in a part of Washington that is crowded with tourists during the summer. The protesters, organized by a group called People’s Action, left messages on the sidewalk in chalk that included “You make us sick,” and “for-profit health ‘care’ killed my mom.”

People’s Action has worked with high-profile progressive lawmakers, including Sen. Elizabeth Warren (D-Mass.), to push for lower drug prices and Medicare for All.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Cancer drug shortages should be causing more outrage
Next article： ASCO Daily Recap: Safety data from Novartis, survival from Pfizer

WSS

FDA approves updated Covid vaccines

At ASCO, pharma leaders speak of advances in 'smart bomb' drugs

WATCH: Why do bright lights make us see spots?

Private equity could exacerbate cardiology's overuse problem, experts fear

WATCH: Why do bright lights make us see spots?

Cord blood banking comes at a high cost to babies

Wikipedia

focus

hotspot

Malaria cases in Florida and Texas: Here’s what you need to know

WATCH: Why do bright lights make us see spots?

Heart attack and stroke risk calculators need revising

Ionis drug prevents swelling attacks due to hereditary angioedema

Jerome Adams on the need for new antivirals for Covid

How to make the FDA’s new prescription one

Anesthesiologist group: stop taking Ozempic before surgery

For one rare type of lung cancer, Pfizer pill reduces progression by 81%

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

Nick Leschly quits Bluebird Bio spinout amid restructuring, layoffs

explore

Change Healthcare can notify patients about the breach, HHS says

What to make of Biden’s latest efforts on cancer research

Diverse clinical trials: Why aren’t we there yet?

Diverse clinical trials: Why aren’t we there yet?

Will the IRA bring competition to the biologics market?

Food makers tried to stack nutrition panel with preferred experts

hotspot

focus

focus

focus